GT Biopharma, Inc.GTBPNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank86
Year-over-Year Change
Price-to-earnings ratio
Latest
-0.13
↑ 99% vs avg
Percentile
P86
Within normal range
Streak
4 yr
Consecutive growthElevated
Average
-14.31
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -0.13 | +71.4% |
| 2024 | -0.44 | +67.6% |
| 2023 | -1.36 | +96.7% |
| 2022 | -40.54 | +8.7% |
| 2021 | -44.41 | -32.5% |
| 2020 | -33.51 | -826.2% |
| 2019 | -3.62 | +4.3% |
| 2018 | -3.78 | +75.7% |
| 2017 | -15.53 | -6570.6% |
| 2016 | 0.24 | - |